Regeneron Pharmaceuticals, Inc. (Tarrytown, NY, USA) and the University of Pennsylvania (Philadelphia, PA, USA) have entered into a collaboration to investigate the delivery of COVID-19 antibody cocktail via the gene therapy platform.
SOURCE: HospiMedica
